Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
TRAW
$0.57
+4.25%
TRAW
· Traws Pharma, Inc.
$0.57
+0.02 (+4.25%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current projections, the Company believes that it does not have sufficient cash and cash equivalents to support its operations for more than one year following the date that these financial statements are issued. As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.66M
Shares
15.37M
Volume · Oct 2
69.63K
Avg daily vol (3M)
570.37K
All webcasts
Earnings call · FY2022 Q4
Traws Pharma, Inc. (TRAW) Q4 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$56,000
+0% YoY
Net income · derived Q4
-$5.42M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 16, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed May 1, 2023 · complete as-filed document